FOP users, I am facing the following problem,An XML file with data is generated and used with XSL to build a PDF. I have alloted fixed heights to each section of the PDF. Now if the DATA to be accomadated in a particular section exceeds the, the whole PDF pattern is altered. The table over flows from the first page to the next and the signature block position also gets altered as i am using co-ordinates from the left bottom corner of the page.
How do i make the PDF layout uniform and get an handle to the signature position, dynamically while post-processing the generated PDF using iText.
I have attached a sample screwed up PDF and XSL for you Reference. Please guide, Thank you Hari <html><DIV><P>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<BR><STRONG><FONT color=#339900>Contribution is not by invitation but by initiative </FONT><BR></STRONG><BR>Hariprasad N Davanagere <BR>19929 Sweetgum Cir, #23<BR>Germantown, MD - 20874</P> <P><STRONG>C - (757) 348 3647 <BR>H - (???) !!! @@@@<BR></STRONG>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ </P></DIV></html>
_________________________________________________________________Sajnaave or Dhoom machaale? http://server1.msn.co.in/sp05/iifa/ Make your favourite song win!
1572.pdf
Description: Adobe PDF document
<?xml version="1.0" encoding="UTF-8"?> <fda> <section1> <Investigator>Kumar Chandran</Investigator> <address>1401 Rockville Pike, Suite 600, Rockville, MD 20852, United States</address> </section1> <section2> <resume attached="yes"/> <other attached="yes"/> </section2> <section3> <organizations> <name>Helen Denit Cancer Center</name> <address>18105 Prince Philip Drive, Suite 200, Olney, MD 20832., United States</address> </organizations> <organizations> <name>Helen Denit Cancer Center</name> <address>18105 Prince Philip Drive, Suite 200, Olney, MD 20832., United States</address> </organizations> <organizations> <name>Helen Denit Cancer Center</name> <address>18105 Prince Philip Drive, Suite 200, Olney, MD 20832., United States</address> </organizations> <organizations> <name>Helen Denit Cancer Center</name> <address>18105 Prince Philip Drive, Suite 200, Olney, MD 20832., United States</address> </organizations> <organizations> <name>Helen Denit Cancer Center</name> <address>18105 Prince Philip Drive, Suite 200, Olney, MD 20832., United States</address> </organizations> </section3> <section4> <labs> <name>Biolab Research Llc</name> <address>121 Congressional Ln Ste 205, Rockville, MD 20852, United States</address> </labs> <labs> <name>Biolab Research Llc</name> <address>121 Congressional Ln Ste 205, Rockville, MD 20852, United States</address> </labs> <labs> <name>Biolab Research Llc</name> <address>121 Congressional Ln Ste 205, Rockville, MD 20852, United States</address> </labs> <labs> <name>Biolab Research Llc</name> <address>121 Congressional Ln Ste 205, Rockville, MD 20852, United States</address> </labs> <labs> <name>Biolab Research Llc</name> <address>121 Congressional Ln Ste 205, Rockville, MD 20852, United States</address> </labs> </section4> <section5> <irbs> <name>IRB00000025 - JHU</name> <address>10810 Connecticut Avenue, Kensington, MD 20895., United States</address> </irbs> <irbs> <name>IRB00000025 - JHU</name> <address>10810 Connecticut Avenue, Kensington, MD 20895., United States</address> </irbs> <irbs> <name>IRB00000025 - JHU</name> <address>10810 Connecticut Avenue, Kensington, MD 20895., United States</address> </irbs> <irbs> <name>IRB00000025 - JHU</name> <address>10810 Connecticut Avenue, Kensington, MD 20895., United States</address> </irbs> <irbs> <name>IRB00000025 - JHU</name> <address>10810 Connecticut Avenue, Kensington, MD 20895., United States</address> </irbs> </section5> <section6 type="PR"> <subinvestigator>Davanagere, Hariprasad</subinvestigator> <subinvestigator>Davanagere, Hariprasad</subinvestigator> <subinvestigator>Davanagere, Hariprasad</subinvestigator> <subinvestigator>Davanagere, Hariprasad</subinvestigator> <subinvestigator>Davanagere, Hariprasad</subinvestigator> <subinvestigator>Davanagere, Hariprasad</subinvestigator> </section6> <section7 type="PR"> <item>Code: T912-56754 Name: Phase II trial of Merbarone (NSC 336628) in patients with metastatic or locally advanced Pancreatic Adenocarcinoma</item> </section7> <section8> <document phase1="yes" phase2or3="no"/> </section8> <section11> <completionDate>03/24/2005</completionDate> </section11> </fda>
--------------------------------------------------------------------- To unsubscribe, e-mail: [EMAIL PROTECTED] For additional commands, e-mail: [EMAIL PROTECTED]
